BMC Rheumatology does not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field. Specific criteria for other article types can be found in the submission guidelines.
Aims and scope
Aims and scope
BMC Rheumatology is an open access, peer-reviewed journal that considers pre-clinical, translational and clinical articles on all aspects of the prevention, treatment and management of rheumatological diseases, related systemic and inflammatory conditions and associated comorbidities, as well as epidemiology, education, pathophysiology, genetics, and drug development.  Â
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.1
5-year Journal Impact Factor: 2.5
Source Normalized Impact per Paper (SNIP): 0.776
SCImago Journal Rank (SJR): 0.805
Speed 2023
Submission to first editorial decision (median days): 15
Submission to acceptance (median days): 247
Usage 2023
Downloads: 398,220
Altmetric mentions: 294
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication